Jubilant Pharmova Arm Launches New High-Speed Isolator-based Line in US Unit

MT Newswires Live

Oct 10, 2025

Jubilant HollisterStier, a wholly-owned subsidiary of Jubilant Pharmova (NSE:JUBLPHARMA, BOM:530019), has launched a new high-speed isolator-based sterile fill and finish line at its Spokane manufacturing facility in the US, according to a Friday filing to the Indian bourses.

The company invested $132 million towards the new third line, which is part of its expansion plan for an additional 50% at the Spokane manufacturing facility.

The commissioning of its upcoming fourth Line, Jubilant HollisterStier, will help Jubilant HollisterStier to double its total sterile injectable manufacturing capacity at its Spokane unit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2574689143"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2574689143\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2574689143?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-10 11:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2574689143","market":"sh","top_or_hot":-1,"title":"Jubilant Pharmova Arm Launches New High-Speed Isolator-based Line in US Unit","media":"MT Newswires Live","content":"<html><body><p> Jubilant HollisterStier, a wholly-owned subsidiary of Jubilant Pharmova (NSE:JUBLPHARMA, BOM:530019), has launched a new high-speed isolator-based sterile fill and finish line at its Spokane manufacturing facility in the US, according to a Friday filing to the Indian bourses.</p><p>The company invested $132 million towards the new third line, which is part of its expansion plan for an additional 50% at the Spokane manufacturing facility.</p><p>The commissioning of its upcoming fourth Line, Jubilant HollisterStier, will help Jubilant HollisterStier to double its total sterile injectable manufacturing capacity at its Spokane unit.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jubilant Pharmova Arm Launches New High-Speed Isolator-based Line in US Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJubilant Pharmova Arm Launches New High-Speed Isolator-based Line in US Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-10 11:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Jubilant HollisterStier, a wholly-owned subsidiary of Jubilant Pharmova (NSE:JUBLPHARMA, BOM:530019), has launched a new high-speed isolator-based sterile fill and finish line at its Spokane manufacturing facility in the US, according to a Friday filing to the Indian bourses.</p><p>The company invested $132 million towards the new third line, which is part of its expansion plan for an additional 50% at the Spokane manufacturing facility.</p><p>The commissioning of its upcoming fourth Line, Jubilant HollisterStier, will help Jubilant HollisterStier to double its total sterile injectable manufacturing capacity at its Spokane unit.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARM","symbol_name":"ARM Holdings","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2574689143","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2574689143","pubTimestamp":1760067989,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Jubilant HollisterStier, a wholly-owned subsidiary of Jubilant Pharmova , has launched a new high-speed isolator-based sterile fill and finish line at its Spokane manufacturing facility in the US, according to a Friday filing to the Indian bourses.The company invested $132 million towards the new third line, which is part of its expansion plan for an additional 50% at the Spokane manufacturing facility.The commissioning of its upcoming fourth Line, Jubilant HollisterStier, will help Jubilant HollisterStier to double its total sterile injectable manufacturing capacity at its Spokane unit.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARM":"ARM Holdings","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","BK4609":"英伟达持仓股","BK4588":"碎股","BK4141":"半导体产品","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","BK4543":"AI","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC"},"translate_title":"Jubilant Pharmova Arm在美国工厂推出基于高速隔离器的新型生产线","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARM":1.5},"content_text":"Jubilant HollisterStier, a wholly-owned subsidiary of Jubilant Pharmova (NSE:JUBLPHARMA, BOM:530019), has launched a new high-speed isolator-based sterile fill and finish line at its Spokane manufacturing facility in the US, according to a Friday filing to the Indian bourses.The company invested $132 million towards the new third line, which is part of its expansion plan for an additional 50% at the Spokane manufacturing facility.The commissioning of its upcoming fourth Line, Jubilant HollisterStier, will help Jubilant HollisterStier to double its total sterile injectable manufacturing capacity at its Spokane unit.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}